AVITI LT
Live / Applied — Second extension granted (statement of use) (as of 13 Nov 2025)
What this means for you
Not registered yet, but its 21 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98143320
- Mark type
- Stylized text
- Filed
- 21 Aug 2023
- Published for opposition
- 08 Oct 2024
- Attorney of record
- Samantha C. Markley
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for laboratory research use; diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for diagnostic laboratory purposes
- Class 005 — Pharmaceuticals: Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for use in diagnostic tests for medical purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use
- Class 009 — Scientific and electric apparatus: Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; instruments for scientific use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis
- Class 010 — Medical apparatus: Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis
- Class 042 — Scientific and technological services: Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings
Owner
- Element Biosciences, Inc., San Diego, CA, US
- Element Biosciences, Inc., San Diego, CA, US
Prosecution history
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 2 GRANTED
- 13 Nov 2025 — SOU EXTENSION 2 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 1 GRANTED
- 02 May 2025 — SOU EXTENSION 1 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 30 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED